2o5d: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2o5d.jpg|left|200px]]
{{Seed}}
[[Image:2o5d.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2o5d|  PDB=2o5d  |  SCENE=  }}  
{{STRUCTURE_2o5d|  PDB=2o5d  |  SCENE=  }}  


'''Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study'''
===Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study===




==Overview==
<!--
A novel series of thiazolone-acylsulfonamides were designed as HCV NS5B polymerase allosteric inhibitors. The structure based drug designs (SBDD) were guided by docking results that revealed the potential to explore an additional pocket in the allosteric site. In particular, the designed molecules contain moieties of previously described thiazolone and a newly designed acylsulfonamide linker that is in turn connected with a substituted aromatic ring. The selected compounds were synthesized and demonstrated low muM activity. The X-ray complex structure was determined at a 2.2A resolution and converged with the SBDD principle.
The line below this paragraph, {{ABSTRACT_PUBMED_17276060}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 17276060 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_17276060}}


==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Structure-based drug design]]
[[Category: Structure-based drug design]]
[[Category: Viral rna-directed rna polymerase]]
[[Category: Viral rna-directed rna polymerase]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 10:20:54 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 20:41:59 2008''